tradingkey.logo
tradingkey.logo
Suchen

MiniMed Ord Shs (Proposed)

MMED
Zur Watchlist hinzufügen
17.360USD
-0.520-2.91%
Handelsschluss 11-10 16:00(ET)
4.88BMarktkapitalisierung
VerlustKGV TTM

Über MiniMed Ord Shs (Proposed) Unternehmen

MiniMed Group, Inc. is a global medical technology company that develops, manufactures, and markets a suite of solutions for the management of diabetes. The Company's fully integrated system addresses two key pain points for PWD: health outcomes and complexity of diabetes management. The MiniMed 780G is its flagship AID system, which consists of the components: the MiniMed 780G insulin pump, its second-generation insulin pump offering enhanced functionality and technological integration with other components of its 780G system; the Simplera Sync or Instinct CGM sensor, which are both easy-to-use, fully disposable, two-step insertion sensors; and its SmartGuard dosing algorithm technology, which automatically delivers basal insulin and auto-correction doses every five minutes based on sensor glucose readings and adapts to ongoing changes in user behavior patterns every night. For PWD that choose to manage their diabetes with MDI instead of an insulin pump, it offers Smart MDI system.

MiniMed Ord Shs (Proposed) Profil

Börsenkürzel- -
Name des Unternehmens- -
IPO-datum- -
CEO- -
Anzahl der mitarbeiter- -
Wertpapierart- -
Geschäftsjahresende- -
Addresse- -
Stadt- -
Börse- -
Land- -
Postleitzahl- -
Telefon- -
Website- -
Börsenkürzel- -
IPO-datum- -
CEO- -

Führungskräfte von MiniMed Ord Shs (Proposed)

Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Chairman of the Board
Independent Chairman of the Board
40.41K
+31.26%
Mr. John Gyurci
Mr. John Gyurci
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
39.57K
+61.27%
Ms. Que Dallara
Ms. Que Dallara
Chief Executive Officer, Director
Chief Executive Officer, Director
34.25K
-2478.02%
Mr. Timothy A. (Tim) Wicks
Mr. Timothy A. (Tim) Wicks
Independent Director
Independent Director
25.68K
+45.92%
Mr. Chad Spooner
Mr. Chad Spooner
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
19.24K
-1785.07%
Mr. Ali Dianaty
Mr. Ali Dianaty
Executive Vice President, Chief Product and Technology Officer
Executive Vice President, Chief Product and Technology Officer
18.32K
+60.62%
Mr. David J. Endicott
Mr. David J. Endicott
Independent Director
Independent Director
15.17K
--
Ms. Amy Bricker
Ms. Amy Bricker
Independent Director
Independent Director
11.88K
--
Ms. Gillian Chandrasena
Ms. Gillian Chandrasena
Chief Human Resources Officer, Senior Vice President
Chief Human Resources Officer, Senior Vice President
7.21K
+24.97%
Mr. Robert A. (Bob) Hopkins
Mr. Robert A. (Bob) Hopkins
Director
Director
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Chairman of the Board
Independent Chairman of the Board
40.41K
+31.26%
Mr. John Gyurci
Mr. John Gyurci
Chief Accounting Officer, Vice President, Controller
Chief Accounting Officer, Vice President, Controller
39.57K
+61.27%
Ms. Que Dallara
Ms. Que Dallara
Chief Executive Officer, Director
Chief Executive Officer, Director
34.25K
-2478.02%
Mr. Timothy A. (Tim) Wicks
Mr. Timothy A. (Tim) Wicks
Independent Director
Independent Director
25.68K
+45.92%
Mr. Chad Spooner
Mr. Chad Spooner
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
19.24K
-1785.07%
Mr. Ali Dianaty
Mr. Ali Dianaty
Executive Vice President, Chief Product and Technology Officer
Executive Vice President, Chief Product and Technology Officer
18.32K
+60.62%

Häufig gestellte Fragen

Wer sind die fünf größten Anteilseigner von MiniMed Ord Shs (Proposed)?

Die fünf größten Anteilseigner von MiniMed Ord Shs (Proposed) sind: Mr. Kevin E. Lofton

Was ist die größte Einnahmequelle von MiniMed Ord Shs (Proposed)?

Am 2026Q1 erzielte das Geschäft mit CGM für MiniMed Ord Shs (Proposed) den höchsten Umsatz in Höhe von 431.00M, was 51.13% des Gesamtumsatzes entspricht.
tradingkey.logo
Risikohinweis: Unsere Website und mobile App bieten lediglich allgemeine Informationen zu bestimmten Anlageprodukten. Finsights stellt keine Finanzberatung oder Empfehlung für ein Anlageprodukt bereit, und die Bereitstellung solcher Informationen darf nicht als Finanzberatung durch Finsights ausgelegt werden.
Anlageprodukte unterliegen erheblichen Anlagerisiken, einschließlich des möglichen Verlusts des investierten Kapitals und sind möglicherweise nicht für jeden geeignet. Die vergangene Wertentwicklung von Anlageprodukten ist nicht unbedingt ein Hinweis auf deren zukünftige Wertentwicklung.
Finsights kann Drittanbietern oder Partnern erlauben, Werbung auf unserer Website oder in unserer mobilen App oder in Teilen davon zu platzieren oder bereitzustellen. Finsights kann für diese Anzeigenvergütung erhalten, basierend auf Ihrer Interaktion mit den Werbeanzeigen.
© Urheberrecht: FINSIGHTS MEDIA PTE. LTD. Alle Rechte vorbehalten.